4//SEC Filing
Azoy Alexander 4
Accession 0001771961-25-000009
CIK 0001724521other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 6:09 PM ET
Size
8.3 KB
Accession
0001771961-25-000009
Insider Transaction Report
Form 4
Azoy Alexander
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-26$13.33/sh+1,900$25,327→ 29,263 total - Sale
Common Stock
2025-11-26$26.00/sh−1,900$49,400→ 27,363 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-26−1,900→ 9,500 totalExercise: $13.33Exp: 2035-01-22→ Common Stock (1,900 underlying)
Footnotes (2)
- [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001771961
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 6:09 PM ET
- Size
- 8.3 KB